{"date":"2026-03-02","count":66,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4116-2026-03-02-2307-92x690","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"23:07:51","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 23:07，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-03-02-2210-u4od5o","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-03-02","time":"22:10:34","subject":"代重要子公司Belite Bio, Inc公告受邀參加Leerink Partners投資銀行舉辦之全球醫療論壇(Leerink Partners GlobalHealthcare Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-03-02 22:10，「代重要子公司Belite Bio, Inc公告受邀參加Leerink Partners投資銀行舉辦之全球醫療論壇(Lee」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2133-guzgkz","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"21:33:32","subject":"本公司董事會通過捐贈財團法人明基文教基金會相關事宜公告","clause":"第43款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 21:33，「本公司董事會通過捐贈財團法人明基文教基金會相關事宜公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2124-1dpjm0i","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"21:24:19","subject":"公告本公司不繼續辦理一一四年股東常會通過之私募有價證券案","clause":"第16款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 21:24，「公告本公司不繼續辦理一一四年股東常會通過之私募有價證券案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2120-ok3q9l","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"21:20:42","subject":"本公司董事會決議辦理現金增資發行普通股參與發行海外存託憑證及/或現金增資發行普通股","clause":"第11款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 21:20，「本公司董事會決議辦理現金增資發行普通股參與發行海外存託憑證及/或現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2112-10ucyw9","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"21:12:17","subject":"本公司董事會決議辦理現金增資私募普通股","clause":"第11款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 21:12，「本公司董事會決議辦理現金增資私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2107-pda6dy","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"21:07:19","subject":"本公司董事會決議辦理私募海外或國內轉換公司債","clause":"第11款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 21:07，「本公司董事會決議辦理私募海外或國內轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2049-1hds7fq","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"20:49:00","subject":"公告本公司董事會通過114年第四季合併財務報告","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 20:49，「公告本公司董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-02-2042-1g32i9f","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"20:42:20","subject":"本公司董事會決議召開115年股東常會日期及開會議程相關事宜公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-02 20:42，「本公司董事會決議召開115年股東常會日期及開會議程相關事宜公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-03-02-2004-11b1948","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-03-02","time":"20:04:05","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-03-02 20:04，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-03-02-1930-n838nv","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-03-02","time":"19:30:04","subject":"本公司向衛生福利部食品藥物管理署(TFDA)申請「安特羅登革熱抗原抗體二合一快速檢測試劑(暫名)」醫療器材查驗登記","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-03-02 19:30，「本公司向衛生福利部食品藥物管理署(TFDA)申請「安特羅登革熱抗原抗體二合一快速檢測試劑(暫名)」醫療器材查驗登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-02-1923-irckeo","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:23:06","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告民事訴訟相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-02 19:23，「代重要子公司合富（中國）醫療科技股份有限公司公告民事訴訟相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-02-1922-1dbnpbp","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:22:54","subject":"公告本公司董事會任命公司治理主管","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-02 19:22，「公告本公司董事會任命公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-02-1922-fqsc9p","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:22:37","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-02 19:22，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-02-1913-jzz98g","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:13:19","subject":"公告本公司收到智慧財產及商業法院商業庭來函有關投保中心請求解任董事職務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-02 19:13，「公告本公司收到智慧財產及商業法院商業庭來函有關投保中心請求解任董事職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-02-1913-1dbkp06","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:13:04","subject":"公告本公司董事長解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-02 19:13，「公告本公司董事長解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-02-1912-1j7kd7z","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:12:38","subject":"公告本公司之法人代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-02 19:12，「公告本公司之法人代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-03-02-1912-9qdkck","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"19:12:20","subject":"公告本公司114年第4季財務報告預計提報董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-03-02 19:12，「公告本公司114年第4季財務報告預計提報董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-03-02-1908-1yojrmg","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"19:08:00","subject":"公告本公司114年度個體及合併財務報告董事會召開日期民國115年03月10日","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-03-02 19:08，「公告本公司114年度個體及合併財務報告董事會召開日期民國115年03月10日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-03-02-1854-5y8knn","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:54:48","subject":"本公司向關係人取得不動產使用權資產","clause":"第20款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-03-02 18:54，「本公司向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-03-02-1846-11b1948","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"18:46:57","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-03-02 18:46，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-03-02-1846-11b1948","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:46:20","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-03-02 18:46，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-03-02-1844-1tvyws7","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:44:50","subject":"公告董事會決議盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-03-02 18:44，「公告董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-03-02-1841-11wjw0o","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:41:35","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-03-02 18:41，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-03-02-1839-5j9yh6","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:39:41","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-03-02 18:39，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-03-02-1830-14462db","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"18:30:07","subject":"公告本公司114年度個體暨合併財務報告預計經董事會決議日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-03-02 18:30，「公告本公司114年度個體暨合併財務報告預計經董事會決議日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-03-02-1826-y8thwo","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:26:55","subject":"公告本公司114年度財務報告董事會預計召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-03-02 18:26，「公告本公司114年度財務報告董事會預計召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-03-02-1823-3po0ig","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"18:23:50","subject":"公告本公司114年度合併暨個體財務報告董事會預計召開日期為115年03月10日","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-03-02 18:23，「公告本公司114年度合併暨個體財務報告董事會預計召開日期為115年03月10日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-03-02-1816-1m7d12f","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"18:16:29","subject":"本公司董事會決議114年股東常會召開事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-03-02 18:16，「本公司董事會決議114年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-03-02-1807-45vd9o","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"18:07:56","subject":"公告本公司2025年度合併財務報告董事會預計召開日期為2026年3月11日","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-03-02 18:07，「公告本公司2025年度合併財務報告董事會預計召開日期為2026年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-03-02-1805-45vd9o","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"18:05:25","subject":"公告本公司2025年度合併財務報告董事會預計召開日期為2026年3月11日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-03-02 18:05，「公告本公司2025年度合併財務報告董事會預計召開日期為2026年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-03-02-1803-92x690","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"18:03:20","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-03-02 18:03，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-02-1759-1kizne2","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:59:28","subject":"代重要子公司豐華生物科技股份有限公司公告董事會決議不分配股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-02 17:59，「代重要子公司豐華生物科技股份有限公司公告董事會決議不分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-02-1759-l8y8ne","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:59:11","subject":"代重要子公司豐華生物科技股份有限公司公告董事會(代行股東會職權)重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-02 17:59，「代重要子公司豐華生物科技股份有限公司公告董事會(代行股東會職權)重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-02-1758-z84jt8","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:58:55","subject":"代重要子公司豐華生物科技股份有限公司公告辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-02 17:58，「代重要子公司豐華生物科技股份有限公司公告辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-03-02-1753-1xl66gd","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:53:54","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-03-02 17:53，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-02-1748-1l8cyf1","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:48:26","subject":"本公司董事會決議召開115年第一次股東臨時會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-02 17:48，「本公司董事會決議召開115年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-03-02-1748-18pxgie","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:48:08","subject":"公告本公司董事會決議114年股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-03-02 17:48，「公告本公司董事會決議114年股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-03-02-1744-fepel0","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:44:06","subject":"公告本公司董事會決議通過115年第4季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-03-02 17:44，「公告本公司董事會決議通過115年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-03-02-1742-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:42:21","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-03-02 17:42，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-03-02-1740-10yb8rh","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:40:08","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-03-02 17:40，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-03-02-1738-pecepz","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:38:02","subject":"114年第4季財務報告董事會預計召開日期為115年3月10日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-03-02 17:38，「114年第4季財務報告董事會預計召開日期為115年3月10日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-02-1729-1nlaaai","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:29:05","subject":"本公司因配合會計師事務所內部輪調機制調整變更簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-02 17:29，「本公司因配合會計師事務所內部輪調機制調整變更簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-03-02-1726-18z6awu","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:26:14","subject":"公告本公司114年第4季合併財務報告董事會預計召開日期為115年3月10日","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-03-02 17:26，「公告本公司114年第4季合併財務報告董事會預計召開日期為115年3月10日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-03-02-1722-1oyzpj2","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:22:25","subject":"代重要子公司American Polylite, Inc.公告內部稽核主管任命案","clause":"第8款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-03-02 17:22，「代重要子公司American Polylite, Inc.公告內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-03-02-1719-664mh5","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:19:56","subject":"公告本公司114年合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-03-02 17:19，「公告本公司114年合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-02-1717-c0asxz","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:17:38","subject":"一一四年第四季財務報告董事會預計召開日期為115/03/10召開日期","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-02 17:17，「一一四年第四季財務報告董事會預計召開日期為115/03/10召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-02-1713-1su03io","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"17:13:05","subject":"公告本公司執行長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-02 17:13，「公告本公司執行長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-03-02-1712-1falb4","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"17:12:47","subject":"公告本公司114年度財務報告董事會預計召開日期為115年03月10日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-03-02 17:12，「公告本公司114年度財務報告董事會預計召開日期為115年03月10日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-02-1654-332yhk","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"16:54:17","subject":"本公司受邀參加凱基證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-02 16:54，「本公司受邀參加凱基證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-02-1653-61p5oe","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"16:53:40","subject":"本公司受邀參加統一證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-02 16:53，「本公司受邀參加統一證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-02-1652-1e8n6dg","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"16:52:31","subject":"公告本公司114年度個別財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-02 16:52，「公告本公司114年度個別財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-03-02-1645-y130ph","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"16:45:30","subject":"公告本公司114年第4季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-03-02 16:45，「公告本公司114年第4季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-03-02-1634-piidf3","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-02","time":"16:34:31","subject":"本公司向衛生福利部食品藥物管理署(TFDA)提出幹細胞新藥思益優GXNPC1治療慢性腦中風第三期人體臨床試驗審查申請。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-03-02 16:34，「本公司向衛生福利部食品藥物管理署(TFDA)提出幹細胞新藥思益優GXNPC1治療慢性腦中風第三期人體臨床試驗審查申請。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-03-02-1624-59xtst","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"16:24:57","subject":"代重要子公司BIOTEQUE MEDICAL PHIL. INC.公告董事會通過自地委建倉庫預算案(補充公告簽約金額)","clause":"第20款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-03-02 16:24，「代重要子公司BIOTEQUE MEDICAL PHIL. INC.公告董事會通過自地委建倉庫預算案(補充公告簽約金額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-03-02-1614-f7zdi0","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"16:14:59","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-03-02 16:14，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-03-02-1536-19nw1jv","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"15:36:56","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月11日","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-03-02 15:36，「公告本公司114年度財務報告董事會預計召開日期為115年3月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-03-02-1515-f7zdi0","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"15:15:39","subject":"公告本公司114年度財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-03-02 15:15，「公告本公司114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-03-02-1507-10jca0t","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"15:07:14","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-03-02 15:07，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-02-1441-y130ph","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"14:41:24","subject":"公告本公司114年第4季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-02 14:41，「公告本公司114年第4季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-03-02-1402-1qj44hg","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"14:02:29","subject":"公告本公司財務主管異動","clause":"第8款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-03-02 14:02，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-03-02-1357-sjl8ul","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"13:57:53","subject":"公告本公司114年度合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-03-02 13:57，「公告本公司114年度合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-03-02-1353-1s5glfa","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"13:53:08","subject":"公告114年度財務報告董事會召開日期","clause":"第31款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-03-02 13:53，「公告114年度財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-02-0939-1q509ln","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"09:39:14","subject":"公告本公司114年第4季合併財務報告董事會召開日期為115年03月13日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-02 09:39，「公告本公司114年第4季合併財務報告董事會召開日期為115年03月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-03-02-0637-11gxmsu","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-03-02","time":"06:37:03","subject":"本公司吸入新藥L608(微脂體-伊洛前列素)，向美國食品藥物管理局(FDA)申請執行人體二期臨床試驗(IND)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-03-02 06:37，「本公司吸入新藥L608(微脂體-伊洛前列素)，向美國食品藥物管理局(FDA)申請執行人體二期臨床試驗(IND)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-02-0002-qj8iux","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-02","time":"00:02:29","subject":"本公司民國114年度財務報告之董事會預計召開日期為民國115年03月09日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-02 00:02，「本公司民國114年度財務報告之董事會預計召開日期為民國115年03月09日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}